1. Introduction {#sec1-ijerph-17-05453}
===============

Ambient particulate matter (PM) is typically considered to be the primary air pollutant, which has been of increasing public concern, and was estimated to have caused 40.93 million deaths and 105.67 million disability-adjusted life-years (DALYs) in 2016 globally \[[@B1-ijerph-17-05453]\]. Particularly, ambient PM contributed greater health impacts to Chinese populations \[[@B2-ijerph-17-05453]\]. Emerging studies have evaluated the adverse effects of PM on cardiovascular disease (CVD). For instance, with a 10 µg/m^3^ increase of the PM~2.5~ (particulate matter with aerodynamic diameter \<2.5 µm) concentration, a nationwide time-series analysis in 272 Chinese cities suggested that PM~2.5~ was related to an increase in daily cardiovascular disease mortality of 0.27% (95% confidence interval: 0.18--0.36) \[[@B3-ijerph-17-05453]\]; other studies \[[@B4-ijerph-17-05453],[@B5-ijerph-17-05453]\] found that exposure to PM~2.5~ contributed to increased cardiovascular hospital admissions in Shandong (0.40% (0.03--0.78)), and Beijing (0.30% (0.20--0.39)) as well. For PM~10~ (particulate matter with aerodynamic diameter \<10 µm), a review study reported a 0.70% (0.60--0.80) increase in cardiovascular mortality per 10 µg/m^3^ increase of the PM~10~ concentration \[[@B6-ijerph-17-05453]\]; PM~10~ exposure was also associated with increased ischemic heart disease mortality (0.86% (0.22--1.51)) \[[@B7-ijerph-17-05453]\] and elevated stroke hospitalizations (1.0% (0.1--1.4)) \[[@B8-ijerph-17-05453]\].

The health costs of air pollution were predicted to achieve \$580 billion globally by 2050 \[[@B9-ijerph-17-05453]\]. Meanwhile, a study indicated that PM~2.5~ pollution should cause a loss of about 2.0% of China's GDP by 2030 if necessary measures are not taken \[[@B10-ijerph-17-05453]\]. There were 290 million CVD cases in China \[[@B11-ijerph-17-05453]\], and CVD accounted for the highest proportion of the total curative care expenditure followed by neoplasm and respiratory diseases \[[@B12-ijerph-17-05453]\]. Nevertheless, few studies have determined the economic burdens of CVD attributable to ambient PM, and previous studies have mainly focused on its health outcomes (e.g., mortality and hospital admission), as described above. Therefore, the assessment of both the health and economic burden is urgently needed, which could provide more comprehensive information for the cost-effectiveness evaluation of policy-making regarding air pollution control.

It was on this basis we conducted our study to determine the association between exposure to ambient PM (including PM~2.5~ and PM~10~) and cardiovascular hospitalizations in Wuhan, China. In addition, we further quantified the CVD hospitalizations and hospitalization expenses attributable to PM~2.5~ and PM~10~; the preventable CVD hospitalizations and savable hospitalization costs were also estimated based on the scenarios that the concentrations of PM~2.5~ and PM~10~ during the study period could be maintained at relatively lower levels.

2. Methods {#sec2-ijerph-17-05453}
==========

2.1. Study Area {#sec2dot1-ijerph-17-05453}
---------------

As the largest metropolis in central China, Wuhan has experienced heavy air pollution in the past few years with the development of urbanization, motorization and industrialization \[[@B13-ijerph-17-05453]\]. Wuhan is located at 113.7--113.1° E and 29.9--31.4° N with an 8569.15 km^2^ total metropolitan area, and the permanent residents were 10.33 million by the end of 2019. The main climate type in Wuhan is humid subtropical monsoon, characterized by hot summers and cold winters as well as short springs and autumns.

2.2. Data Collection {#sec2dot2-ijerph-17-05453}
--------------------

Daily hospitalization admission data between 1 January 2015 and 31 December 2017 were obtained from two general hospitals in Wuhan; both the chosen hospitals are Grade-A tertiary hospitals with well-known expertise in diagnosing and treating disease. Records of hospital admissions included admission date, age, gender, principal discharge diagnosis and hospitalization costs, and the diagnosis of disease was coded according to the International Classification of Disease Tenth Revision (ICD-10). Patients hospitalized due to CVD (ICD-10: I00-I99) were included in our study; the entire study group was divided into two gender groups (male and female) and two age groups (0--64 years and +65 years). Further break-down of the 0--64 years group was not conducted because the children group (0--14 years) only accounted for 0.24% of the total cases. Besides, two subtypes of CVD including ischemic heart disease (IHD, ICD-10: I20-I25) and stroke (ICD-10: I60-I69) were also analyzed.

Data of ambient air pollutants including PM~2.5~, PM~10~, SO~2~ (sulfur dioxide) and NO~2~ (nitrogen dioxide) were acquired from the Hubei Environmental Protection Bureau; the daily mean concentration (µg/m^3^) for each air pollutant was calculated by averaging across the measurements from the 10 monitoring stations in Wuhan. Daily meteorological data were collected from the China Meteorological Data Network (<http://data.cma.cn>), including mean air temperature (°C) and relative humidity (%). The spatial distribution of included hospitals and air monitoring sites are displayed in [Figure S1](#app1-ijerph-17-05453){ref-type="app"}.

2.3. Data Analysis {#sec2dot3-ijerph-17-05453}
------------------

A three-stage analytic approach was used to analyze the data. Firstly, we decomposed the time-series data (including PM concentration, CVD hospitalizations and hospitalization costs) to detect a potential long-term trend and seasonality. Secondly, we applied a time-series model to estimate PM-hospitalization associations. Thirdly, we calculated the hospitalizations and hospitalization costs attributable to PM~2.5~ and PM~10~.

### 2.3.1. First-Stage Analysis {#sec2dot3dot1-ijerph-17-05453}

A seasonal-trend decomposed method was used to detect a potential long-term trend and seasonality of the daily concentration of PM (PM~2.5~ and PM~10~), daily hospitalizations and case-average hospitalization costs. The time-series was split into three additive components, including a long-term trend during the study period, seasonal variations within years and random variation \[[@B14-ijerph-17-05453],[@B15-ijerph-17-05453]\]; the fundamental statistical model was as shown:$$Y_{t} = T_{t} + S_{t} + R_{t}$$ where $T_{t}\ $ is the linear trend; $S_{t}$ is the seasonal effect; $I_{t}\ $ is the r random noise and *t* = 1, 2, ...., N.

### 2.3.2. Second-Stage Analysis {#sec2dot3dot2-ijerph-17-05453}

The associations of PM~2.5~ and PM~10~ with CVD hospitalizations were estimated by using a generalized additive model (GAM) with quasi-Poisson regression as shown:$$\log\left( E_{i} \right) = \beta_{i}\left( {PMC_{i}} \right) + s\left( {TIME,df} \right) + s\left( {MT,df} \right) + s\left( {RH,df} \right) + DOW + a$$ where $E_{i}$ is the expected hospitalizations on day *i*, $\beta_{i}\ $ is the estimated slope of associations of the concentrations of PM~2.5~ or PM~10~ on day *i*, *s* is a spline smoothing function for the nonlinear variable (e.g., time, mean temperature and relative humidity), *df* is the degree of freedom---7 *df* per year for time trends \[[@B15-ijerph-17-05453],[@B16-ijerph-17-05453]\] and 3 *df* per year for mean temperature and relative humidity were defined \[[@B17-ijerph-17-05453]\], *DOW* is a categorical variable for day of the week and $\alpha$ is the intercept of the model.

Effect estimates across lag0 day (the day of hospital admission) to lag7 day (7 days prior to hospital admission) were investigated in our current study, which were presented as a percent change (*PC*, %), and the 95% confidence interval (CI) in daily CVD hospitalizations was associated with a 10 µg/m^3^ increase in the concentrations of PM~2.5~ or PM~10~. *PC* was calculated through Equation (3):$$PC = \left\lbrack {\exp\left( {\beta_{i} \times 10} \right) - 1} \right\rbrack \times 100$$ where $\beta_{i}\ $ is the estimated slope of associations of the concentrations of PM~2.5~ or PM~10~ on day *i*, which was obtained from Formula (2).

### 2.3.3. Third-Stage Analysis {#sec2dot3dot3-ijerph-17-05453}

The attributable fraction (*AF*) and attributable number (*AN*) of CVD hospitalizations due to PM~2.5~ or PM~10~ were estimated by using the method mentioned previously \[[@B18-ijerph-17-05453],[@B19-ijerph-17-05453],[@B20-ijerph-17-05453],[@B21-ijerph-17-05453]\]. The following, Equations (4) and (5), were used:$$AF_{i} = 1 - \frac{1}{\exp\left( {\beta_{i}*\Delta C_{i}} \right)}$$ $$AN_{i} = AF_{i} \times N_{i}$$ where $\ AF_{i}\ $ is the attributable fraction on day *i,* $AN_{i}\ $ is the attributable number of CVD hospitalizations on day *i*, $N_{i}\ $ is the daily CVD hospitalizations on day *i* and $\beta_{i}\ $ is the estimated slope of associations of the concentrations of PM~2.5~ or PM~10~ on day *i*. $\Delta C_{i}$ is the concentration difference between the observed and the reference concentrations of PM~2.5~ or PM~10~ on day *i*. The reference concentration is a threshold level at which no health effects are yet assumed, then the air quality standard proposed by the World Health Organization (WHO) was considered as the threshold (24 h average value: 25 µg/m^3^ for PM~2.5~ and 50 µg/m^3^ for PM~10~) in our current study \[[@B20-ijerph-17-05453]\].

Therefore, the total attributable number was estimated by summing daily $AN$, and its ratio with total CVD hospitalizations was the total *AF*. We further calculated the total attributable hospitalization costs via multiplying the total attributable number by the case-average hospitalization costs during the study period \[[@B20-ijerph-17-05453],[@B22-ijerph-17-05453]\]. The potential number of avoidable hospitalizations and savable hospitalization costs were also estimated based on the scenarios that the concentrations of PM~2.5~ and PM~10~ during the study period could be maintained at relatively lower levels. All the costs were presented as the 2020 price in Renminbi using a consumer price index for adjustment (1 RMB = 0.1424 USD).

### 2.3.4. Sensitivity Analysis {#sec2dot3dot4-ijerph-17-05453}

A sensitivity analysis was performed to examine the robustness of the model through: (1) adjusting for co-pollutants (SO~2~ and NO~2~) and (2) changing the degree of freedom (*df* = 8 and 9) for the long-term trend and seasonality.

All analyses were conducted by R software (version 3.6.1, R Foundation for Statistical Computing, Vienna, Austria), and two-sided tests with *p* \< 0.05 were considered to be statistically significant.

2.4. Ethical Approval {#sec2dot4-ijerph-17-05453}
---------------------

All the data in our study were anonymous and de-identified, and it was approved by the Ethics Committee of the Medical Department of Wuhan University to waive informed consent of the participants (No. 2019YF2037).

3. Results {#sec3-ijerph-17-05453}
==========

A total of 45,714 CVD hospitalizations from 1 January 2015 to 31 December 2017 were included in this study, of which IHD and stroke, respectively, accounted for 20.77% and 38.29%. [Table 1](#ijerph-17-05453-t001){ref-type="table"} provides the summary statistics of daily hospitalization counts, hospitalization costs, air pollutant concentration and meteorological factors in Wuhan, China, from 2015--2017. On average, there were 42 admission cases per day for CVD, 9 cases for IHD and 16 cases for stroke. The daily CVD hospitalizations of males were obviously higher than that of females, and there were less daily CVD hospitalizations for patients aged 0--64 years compared with the older group (65+ years). The average hospitalization costs for CVD, IHD and stroke were 19,680 RMB, 19,320 RMB and 24,290 RMB, respectively. Higher mean CVD-associated costs were observed for males and patients aged 0--64 years.

The annual average concentrations of PM~2.5~ and PM~10~ were 58.52 µg/m^3^ and 96.10 µg/m^3^ in Wuhan; both exceeded the secondary standard of ambient air quality in China (annual average value: 35µg/m^3^ for PM~2.5~ and 70 µg/m^3^ for PM~10~). In addition, the annual mean temperature and relative humidity were 17.20 °C and 80.62%, respectively. Spearman's rank correlation indicated that PM~2.5~ and PM~10~ were moderately correlated with SO~2~ and NO~2~, while they were slightly correlated with meteorological factors (see [Table S1](#app1-ijerph-17-05453){ref-type="app"}).

The long-term trend and seasonality of the daily concentrations of PM~2.5~ and PM~10~, daily hospitalizations and case-average hospitalization costs due to CVD are shown in [Figure 1](#ijerph-17-05453-f001){ref-type="fig"}. During the study period, the daily concentrations of PM~2.5~ and PM~10~ had similar characteristics of periodic fluctuation with a downtrend annually, the seasonal pattern of which showed a high concentration in winter and spring while a low concentration in summer and autumn. However, daily CVD hospitalizations and case-average hospitalization costs increased over the three-year study period without notable seasonal fluctuations. Similar trends in hospitalizations and costs were also noted for IHD and stroke (see [Figure S2](#app1-ijerph-17-05453){ref-type="app"}).

[Figure 2](#ijerph-17-05453-f002){ref-type="fig"} illustrates the estimated percent changes (%, 95% CI) of hospitalization risks associated with a 10 µg/m^3^ increase in PM~2.5~ and PM~10~ concentrations at different lag days in single-pollutant models. We found evidence for significant positive associations for at least two exposure lag days between the PM~2.5~ concentration and hospital admissions for all cardiovascular outcomes. The strongest effects were noted at lag7 day; the corresponding percent changes of hospitalizations for CVD, IHD and stroke were 1.01% (0.67--1.34), 1.10% (0.37--1.84) and 1.01% (0.45--1.56), respectively. With a 10 µg/m^3^ increase in PM~10~, significant percent changes of cardiovascular hospitalizations first occurred at lag2 day with the exception of strokes. Likewise, estimated values reached the peak at lag7 day, and were 0.48% (0.26--0.70), 0.58% (0.11--1.07) and 0.61% (0.25--0.96) for CVD, IHD and stroke, respectively. To ease the interpretation, the lag7 day concentrations of PM~2.5~ and PM~10~ are further analyzed in the following paragraphs, since these days produced the largest effect estimates.

Results of subgroup analyses of CVD hospitalizations are presented in [Figure 3](#ijerph-17-05453-f003){ref-type="fig"}. There was no notable gender difference for PM~2.5~, whereas males were more vulnerable to PM~10~ (0.51% (0.22--0.79)) than females (0.44% (0.11--0.77)). For age group, greater estimated values were found for the group aged 0--64 years; the percent changes of PM~2.5~ and PM~10~ were 1.05% (0.53--1.56) and 0.57% (0.24--0.91), respectively. Subgroup analyses of IHD and stroke are presented in [Figures S3 and S4](#app1-ijerph-17-05453){ref-type="app"}, and significant differences were found by gender and age groups.

[Table 2](#ijerph-17-05453-t002){ref-type="table"} demonstrates the estimated attributable figures for different CVD observations during the study period. For all CVD, 1487 and 983 hospitalizations were, respectively, attributable to PM~2.5~ and PM~10~, which corresponded to 29.27 million RMB and 19.34 million RMB. Both attributable hospitalizations and attributable hospitalization costs were higher in males than in females. In addition, there were more attributable hospitalizations due to PM~2.5~ for the group aged 65+ years than the younger group (0--64 years), while the opposite results were produced by PM~10~. In addition, there were 340 and 249 IHD-related hospitalizations attributable to PM~2.5~ and PM~10~, and the associated attributable hospitalization costs were 6.57 million RMB and 4.82 million RMB, respectively. For stroke, 13.35 million RMB and 8.98 million RMB were attributable to PM~2.5~ and PM~10~, and the attributable hospitalizations were 550 and 465, respectively.

[Figure 4](#ijerph-17-05453-f004){ref-type="fig"} illustrates the potential number of avoidable hospitalizations and savable hospitalization costs if the concentration of PM~2.5~ and PM~10~ during the study period could be maintained at relatively low levels. For total CVD, maintaining the PM~2.5~ concentration at 45 µg/m^3^ could prevent 193 hospitalizations and save 3.8 million RMB annually. In addition, if the PM~10~ concentration could be maintained at 90 µg/m^3^, 39 hospitalizations could be avoided annually, reducing 0.8 million RMB correspondingly. It seems obvious that more hospital admissions and hospitalization costs could be avoided if the historical concentrations of PM~2.5~ and PM~10~ are kept at lower levels, such that if the PM~2.5~ concentration is kept at 30 µg/m^3^, 420 hospitalizations and 8.3 million RMB could be avoided annually, and if the concentration of PM~10~ is maintained at 60 µg/m^3^, 255 hospitalizations and 5.0 million RMB could be averted annually. In addition, more health and economic benefits could be obtained for stroke than IHD. For instance, if the historical concentration of PM~2.5~ is maintained at 45 µg/m^3^, more stroke-associated hospitalizations and costs (68 and 1.5 million RMB, respectively) could be prevented than IHD (45 and 0.9 million RMB, respectively). More details about the subgroup analysis are showed in the [supplementary material](#app1-ijerph-17-05453){ref-type="app"} (see [Figure S5](#app1-ijerph-17-05453){ref-type="app"}).

Sensitivity analyses of adjusted co-pollutants in the model (SO~2~ and NO~2~) and changed *df* (8 and 9) for the long-term trend and seasonality were performed, which suggested that our main models were generally robust (See [Table S2](#app1-ijerph-17-05453){ref-type="app"}).

4. Discussion {#sec4-ijerph-17-05453}
=============

Some notable results were found in this time-series study in Wuhan, China. First, the daily concentration of ambient PM showed a downtrend, while daily cardiovascular hospitalizations and hospitalization costs increased during the study period. Second, exposure to PM~2.5~ and PM~10~ were associated with an excess risk of CVD hospitalization, and differences were found by gender and age groups. Third, substantial economic costs were attributed to PM~2.5~ and PM~10~ exposure; millions of hospitalization costs could be avoided if the historical PM concentration is maintained at relatively low levels.

In this study, we conducted a decomposed method to detect the potential long-term trend and seasonality of the daily concentration of ambient PM, daily hospitalizations and case-average hospitalization costs. Possibly as a result of strengthened measures taken by the local government to control ambient air pollution recently, a trend of a decline in the PM concentration from 2015 to 2017 was observed. The ambient PM concentration was relatively high in winter and spring; such a seasonal pattern could be interpreted by the increased burning of coal to provide central heating in the cold season that might cause more PM. Another reason might be that temperature inversion is common in the cold season, which would inhibit the spread of air pollutants. However, both daily CVD hospitalizations and corresponding average hospitalization costs performed uptrends during the study period, echoing a study \[[@B23-ijerph-17-05453]\] that suggested that the prevalence of non-communicable diseases was increasing worldwide, especially for CVD. A natural cubic spline for time with 7 *df* per year was commonly used to control for the long-term trend of daily hospital admissions \[[@B15-ijerph-17-05453],[@B16-ijerph-17-05453],[@B24-ijerph-17-05453]\]. In addition, with the growth of per-capita income and chronic disease morbidity, rates of patients leaving against medical advice and avoiding the hospital decreased \[[@B25-ijerph-17-05453]\], contributing to the increase of hospitalization expenses.

In line with previous studies, our results reported that PM was associated with an excess risk of CVD hospitalization. For example, with a 10 µg/m^3^ increment of the PM concentration, a 0.87% increase in cardiovascular hospital admissions due to PM~2.5~ \[[@B13-ijerph-17-05453]\] and 1.0% increase in stroke hospitalizations due to PM~10~ \[[@B8-ijerph-17-05453]\] were found in Wuhan. In addition, other researchers observed consistently increased hospitalizations associated with PM~2.5~ and PM~10~ for CVD in some Chinese regions such as Shandong \[[@B4-ijerph-17-05453]\], Beijing \[[@B5-ijerph-17-05453]\], Shanghai \[[@B26-ijerph-17-05453]\] and Sichuan \[[@B27-ijerph-17-05453]\]. Moreover, studies \[[@B28-ijerph-17-05453],[@B29-ijerph-17-05453]\] of Brazil, France, Iran and Italy also demonstrated the positive associations between PM exposure and cardiovascular hospitalizations. Ambient PM mainly comes from fossil fuel combustion and automobile exhaust, which contains toxic organic compounds such as benzopyrene and many heavy metals (e.g., lead, nickel and chromium) \[[@B30-ijerph-17-05453]\]. Previous clinical and toxicological studies have established several possible mechanisms for how PM and its components adversely impact the cardiovascular system. For instance, Cao et al. \[[@B31-ijerph-17-05453]\] indicated that PM could lead to cardiomyocyte apoptosis by protein kinase activation, and Kowalska et al. \[[@B32-ijerph-17-05453]\] suggested that PM contributed to myocardial infarction via destabilizing atherosclerotic plaques. Other researchers also found that PM was related to acute decompensated heart failure symptoms \[[@B33-ijerph-17-05453],[@B34-ijerph-17-05453]\], decreased heart rate variability and changed autonomic tone \[[@B35-ijerph-17-05453],[@B36-ijerph-17-05453]\].

Gender and age differences in associations of particulate pollution with cardiovascular health have been of wide interest in air pollution epidemiology. We found that the impacts of PM on CVD were significantly greater in males, which is consistent with a study in Shanghai \[[@B26-ijerph-17-05453]\], while other studies \[[@B5-ijerph-17-05453],[@B37-ijerph-17-05453]\] showed that the gender differences were statistically insignificant. Similar with previous studies \[[@B13-ijerph-17-05453],[@B38-ijerph-17-05453]\], a greater increase of CVD hospitalizations for the younger group (0--64 years) was also observed in our current study. However, a study of Powell et al. \[[@B39-ijerph-17-05453]\] suggested stronger associations between daily CVD hospital admissions and particulate air pollution were observed for the elderly. Considering the gender and age group specific associations were varied, the likely explanation for the heterogeneity might be various study designs, research periods and sociodemographic and economic characteristics.

Economic burden assessment is crucial for the cost-effectiveness evaluation of policy-making regarding air pollution control. A study of Tianjin \[[@B40-ijerph-17-05453]\] calculated that attributable CVD mortalities due to PM~2.5~ were equivalent to 2.79% of the local GDP when converted into present value, and Cheng et al. \[[@B16-ijerph-17-05453]\] demonstrated that 21 million RMB CVD-associated hospitalization expenses could be saved annually in Lanzhou if the concentration of CO is kept below 1 mg/m^3^. Other studies in regard to mental disorders \[[@B20-ijerph-17-05453]\] and pneumonia \[[@B22-ijerph-17-05453]\] also showed that a certain amount of medical expenses could be avoided with the decline of PM concentrations. Correspondingly, our current study illustrated that 29.27 million RMB and 19.34 million RMB were, respectively, attributed to PM~2.5~ and PM~10~, and more hospitalization costs could be saved if the historical concentration of PM is maintained at lower levels. To some extent, our study might fill some of the gaps of knowledge about the health economic aspects of particulate air pollution on CVD in central China, and further studies should focus on other air pollutants on cardiovascular health.

The present study had some limitations. First, the average concentration of PM in Wuhan was considered as personal exposure, which may cause measurement errors. It is a well-recognized inherent limitation of such environmental epidemiological studies \[[@B41-ijerph-17-05453]\] that is likely to underestimate the effects of PM \[[@B42-ijerph-17-05453]\]. Second, the influences of meteorological factors, day of the week, gender and age were considered in our current study, and more individual information such as socio-economic status and behavioral factors could also be considered in follow-up studies. Third, the economic burden calculated in this study tended to understate the real economic burden of CVD due to PM, since the economic cost in our results only included the direct hospitalization expenses, while the indirect medical costs and outpatient expenditures were not analyzed. Consequently, more research should be undertaken to resolve these issues.

5. Conclusions {#sec5-ijerph-17-05453}
==============

In conclusion, we found that ambient particulate pollution increased CVD risk and cost among hospital admission patients in Wuhan, one of the heavily polluted megacities in central China. Then, we should continue to strengthen the efforts to alleviate the level of particulate pollution in Wuhan, which would certainly reduce the health and economic burden among patients with CVD. Our study also highlights the demand for evaluating the air pollution-related economic effect. It may have important implications for promoting the cost-effectiveness evaluation of measures regarding air pollution control, thereby providing informative priorities about measures with the largest benefits for local decision-makers from the public health perspective.

The following are available online at <https://www.mdpi.com/1660-4601/17/15/5453/s1>. Figure S1: The spatial distribution of included hospitals and air monitoring sites in Wuhan, China. Figure S2: The decomposed distribution of daily hospitalizations (no.) and case-average hospitalization costs due to IHD (A and B) and stroke (C and D) in Wuhan, China, from 2015--2017. Figure S3: The estimated percent change of IHD hospitalizations of per 10 µg/m^3^ increase in PM~2.5~ and PM~10~ concentrations, by gender and age group. PC: percent change, CI: confidence interval. Figure S4: The estimated percent change of stroke hospitalizations per 10 µg/m^3^ increase in PM~2.5~ and PM~10~ concentrations, by gender and age group. PC: percent change, CI: confidence interval. Figure S5: The estimated annual avoidable hospitalizations and savable hospitalization costs for CVD subgroups if the historical concentrations of PM~2.5~ and PM~10~ could be maintained at relatively low levels. The air quality standard proposed by the WHO (24-h average value: 25 µg/m^3^ for PM~2.5~ and 50 µg/m^3^ for PM~10~) was considered as the reference. Table S1: The coefficient of the Spearman rank correlation between particulate matter (including PM~2.5~ and PM~10~) and SO~2~, NO~2~ and meteorological factors in Wuhan, China. Table S2: Results of sensitivity analyses by adjusting for co-pollutants and changing the degree of freedom for the long-term trend and seasonality. Results are shown in percent change (%) per 10 µg/m^3^ increase in PM~2.5~ and PM~10~ concentrations at the best lag day.
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ijerph-17-05453-t001_Table 1

###### 

Summary statistics of daily hospitalization counts, hospitalization costs, air pollutant concentration and meteorological factors in Wuhan, China, from 2015--2017.

  Variable                              Mean    SD      Min    Percentile   Max             
  ------------------------------------- ------- ------- ------ ------------ ------- ------- ---------
  Daily hospitalization counts                                                              
  CVD                                   42      17.79   2      28           41      53      97
  IHD                                   9       4.45    0      5            8       12      25
  Stroke                                16      6.62    0      11           16      20      43
  Males                                 24      10.76   2      15           23      31      58
  Females                               18      8.25    0      12           17      23      46
  0--64 years                           18      8.77    0      12           17      23      53
  64+ years                             24      10.34   1      16           23      31      60
  Hospitalization costs (in 1000 RMB)                                                       
  CVD                                   19.68   31.08   0.04   6.25         10.05   19.12   1036.81
  IHD                                   19.32   25.59   0.13   6.70         10.30   20.70   1036.81
  Stroke                                24.29   37.32   0.07   6.76         11.78   23.84   946.95
  Males                                 21.22   32.64   0.04   6.53         10.94   21.16   1036.81
  Females                               17.68   28.79   0.08   5.95         9.01    16.49   728.54
  0--64 years                           21.22   34.91   0.04   5.84         9.44    18.20   657.65
  64+ years                             18.53   27.78   0.07   6.58         10.41   19.62   1036.81
  Air pollutants (µg/m^3^)                                                                  
  PM~2.5~                               58.52   38.56   4      31           49      76      281
  PM~10~                                96.10   51.10   10     60           90      124     618
  SO~2~                                 13.39   8.85    3      7            11      17      74
  NO~2~                                 46.17   19.37   11     31           43      57      119
  Meteorological factors                                                                    
  Mean temperature (°C)                 17.20   8.94    −3.8   9.2          18      24.7    33.9
  Relative humidity (%)                 80.62   10.38   42     74           82      88      100

Notes: CVD, cardiovascular disease; IHD, ischemic heart disease; SD, standard deviation; P~25~, 25th percentile; P~50~, 50th percentile; P~75~, 75th percentile.

ijerph-17-05453-t002_Table 2

###### 

The number of hospitalizations and hospitalization costs attributable to PM~2.5~ and PM~10~ in Wuhan, China, from 2015--2017.

  Variable      Attributable Hospitalizations (No.)   Attributable Hospitalization Costs (RMB, Million)                          
  ------------- ------------------------------------- --------------------------------------------------- ---------------------- ----------------------
  CVD           1487 (1007, 1956)                     983 (541, 1415)                                     29.27 (19.81, 38.85)   19.34 (10.65, 27.85)
  IHD           340 (119, 549)                        249 (49, 441)                                       6.57 (2.29, 10.53)     4.82 (0.94, 8.53)
  Stroke        550 (245, 834)                        465 (199, 722)                                      13.35 (6.16, 20.94)    8.98 (3.84, 13.94)
  Males         855 (777, 932)                        460 (388, 531)                                      18.14 (16.48, 19.27)   9.76 (8.24, 11.27)
  Females       653 (335, 959)                        390 (95, 675)                                       11.54 (5.91, 16.93)    6.89 (1.68, 11.93)
  0--64 years   653 (339, 955)                        497 (212, 773)                                      13.85 (7.19, 20.40)    10.55 (4.51, 16.40)
  65+ years     1118 (1035, 1199)                     471 (393, 548)                                      20.71 (19.18, 22.15)   8.72 (7.28, 10.15)

Notes: The air quality standard proposed by the WHO (24-h average value: 25 µg/m^3^ for PM~2.5~ and 50 µg/m^3^ for PM~10~) was considered as the reference.
